LevelJump Healthcare Reports $1.56 Million In Revenue For Q1 2021

LevelJump Healthcare Corp. (TSXV: JUMP) announced last week its financial results for Q1 2021, which recorded $1.56 million revenue. This is an increase from last year’s revenue of $1.28 million for the three month period.

Gross profit for the quarter came in at $0.31 million, a climb from the previous year’s $0.25 million. The company said it continues to see increased volume from current clients and the new hospital network added during the quarter, despite limited hospital activities due to the ongoing pandemic.

The company posted a net loss of $0.70 million for the quarter, compared to last year’s net profit of $0.10 million. The loss can be attributed to a $0.39 million stock-based compensation expense. Adding this back, among other expenses, the company’s adjusted EBITDA is at a negative $0.21 million. 

The company ended the quarter with $0.60 million in cash and cash equivalents, down from last quarter’s $0.91 million, with the company having conducted a financing to the tune of $1.5 million following the end of the quarter. LevelJump CEO Mitch Geisler relayed that “the recent private placement strengthened [the company’s] cash position and aligned strategic investors with [its] long-term corporate vision.”

LevelJump Healthcare Corp. last traded at $0.35 on the TSX Venture.


FULL DISCLOSURE: Leveljump Healthcare Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Leveljump Healthcare Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold’s Next 12 Months Will Be the Trade of a Lifetime | Simon Marcotte – Northern Superior

Will The Government Will Quietly End The Dollar Using Gold | Andy Schectman

The Japanese Gold Mining Advantage | John Proust – Japan Gold

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

The Next Big Canadian Telehealth Stock? – The Daily Dive feat Mitch Geisler of Leveljump Healthcare

Starting off the short Canadian trading week for the Daily Dive is that of Mitch...

Tuesday, December 29, 2020, 01:30:00 PM

Leveljump Takes Minority Stake In Radiology Service Provider

Leveljump Healthcare (TSXV: JUMP) is looking to expand its current portfolio. The company last night...

Friday, November 26, 2021, 08:31:25 AM

Leveljump Receives Approval For Listing Of Warrants On TSX Venture

Leveljump Healthcare (TSXV: JUMP) this morning has seen the TSX Venture approve the previously announced...

Monday, March 8, 2021, 08:46:10 AM

Leveljump Healthcare Reports 2020 Revenues Of $5.45 Million, Net Loss Of $11.6 Million

Leveljump Healthcare (TSXV: JUMP) today reported its fiscal 2020 financial results. The company recognized revenues...

Friday, April 16, 2021, 01:51:41 PM

Leveljump Healthcare Looks To List Warrants On TSX Venture

Leveljump Healthcare (TSXV: JUMP) is looking to provide additional liquidity to its investors. The firm...

Friday, February 5, 2021, 08:32:44 AM